National Comprehensive Cancer Network



About NCCN

Ovarian Cancer Panel - Disclosures as of 7/29/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

Morphotek Inc.;
Merrimack;
Pfizer Inc.

Amgen Inc.

None

None

10/11/2013

Deborah K. Armstrong, MD

Genentech, Inc.;
MedImmune Inc.;
Morphotek Inc.;
Astellas;
Merrimack

Morphotek Inc.

None

None

10/11/2013

Kian Behbakht, MD

       

Pending

Jennifer Burns

None

None

None

None

7/10/2014

Lee-may Chen, MD

None

None

None

None

4/11/2013

Larry Copeland, MD

Gynecologic Oncology Group;
Teasro

Endocyte;
Oxigene

None

None

7/20/2014

Marta Ann Crispens, MD

AstraZeneca Pharmaceuticals LP;
Novartis Pharmaceuticals Corporation;
Merrimack Pharmaceuticals;
Spirogen

None

None

None

5/5/2014

Oliver Dorigo, MD, PhD

       

Pending

Mary Dwyer, MS

None

None

None

None

3/7/2014

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

David M. Gershenson, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
GlaxoSmithKline;
National Cancer Institute;
Pfizer Inc.

None

Johnson & Johnson;
Merck & Co., Inc.;
Elsevier;
Informa;
Proctor and Gamble;
Up to Date

National Cancer Institute

10/11/2013

Heidi J. Gray, MD

Abbott Laboratories;
Prima Biomed

Prima Biomed

None

None

4/24/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Ardeshir Hakam, MD

None

None

None

None

5/1/2014

Laura J. Havrilesky, MD

None

None

None

None

10/28/2013

Miranda Hughes, PhD

None

None

None

None

4/21/2014

Carolyn Johnston, MD

None

None

None

american cancer society document reviewer;
american cancer society-great lakes division;
michigan cancer consortium;
MPRO

10/27/2013

Shashikant Lele, MD

None

None

None

None

9/5/2013

Lainie Martin, MD

None

Clovis Oncology

None

None

2/4/2014

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.

Merck & Co., Inc.;
Clovis;
Pathway Therapeutics;
Tesaro

None

None

10/28/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

Robert J. Morgan, MD, FACP

NIH-CTEP

None

None

None

3/12/2013

David M. O'Malley, MD

Genentech, Inc.

None

None

None

3/20/2013

Richard T. Penson, MD, MRCP

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
Endocyte Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Biomarin Pharmaceuticals, Inc.;
Clovis Oncology;
Lifecore Biomedical

None

None

3/7/2013

Steven C. Plaxe, MD, FACOG, FACS

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
azaya;
endocyte;
Tesaro;
Pfizer Inc.

None

Abbott Laboratories;
Bristol-Myers Squibb Company;
Pfizer Inc.

insys

5/1/2014

Matthew A. Powell, MD

Bristol-Myers Squibb Company;
Eisai Inc.

AnorMED Inc.

None

None

4/10/2013

Steven W. Remmenga, MD

None

None

None

None

5/2/2014

Paul Sabbatini, MD

Prim Biomed

None

None

None

3/22/2014

Joseph T. Santoso, MD

None

Jannsen Pharmaceutica Products, LP;
lab cor;
vermillion

None

None

1/20/2014

Theresa L. Werner, MD

None

None

None

None

5/2/2014